Volunteer for NIAID-funded clinical studies related to antimicrobial (drug) resistance on ClinicalTrials.gov.
Microbes, collectively, include bacteria, viruses, fungi, and parasites. For the past 70 years, antimicrobial drugs, such as antibiotics, have been successfully used to treat patients with bacterial and infectious diseases. Over time, however, many infectious organisms have adapted to the drugs designed to kill them, making the products less effective. To address this growing problem, NIAID is funding and conducting research on many aspects of antimicrobial (drug) resistance, including basic research on how microbes develop resistance, new and faster diagnostics, and clinical trials designed to find new vaccines and treatments effective against drug-resistant microbes.
NIAID's Antibacterial Resistance Program: Current Status and Future Directions 2014 (PDF)—Feb. 4, 2014
Media Availability: Researchers Launch Phase 1 Clinical Trial of Potential MRSA Treatment—Jan. 24, 2014
Two New Promising Treatment Regimens for Gonorrhea—July 15, 2013
NIH to Fund Clinical Research Network on Antibacterial Resistance—June 3, 2013
Last Updated February 04, 2014
Last Reviewed April 13, 2011